CYTéVIE SRL
Ouverture de failliteCYTéVIE reported total assets of 82,151 € at the end of the 2024 financial year (annual accounts filed with the NBB on 23 Jul 2025).
The score of CYTéVIE shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity -97 % Total assets -43 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CYTéVIE's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 23 Jul 2025
- Year ended 31 Dec 2023filed on 27 Sep 2024
- Year ended 31 Dec 2022filed on 19 Jun 2023
- Year ended 31 Dec 2021filed on 20 Jun 2022
- Year ended 31 Dec 2020filed on 16 Jul 2021
CYTéVIE's financial analysis
- Solvency2.5%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CYTéVIE
CYTéVIE's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0474.812.921
- VAT number
- BE0474812921
- Peppol
- Registered · 0208:0474812921 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 May 2001
- Registered office
- 4170 Comblain-au-Pont
- Latest accounts
- 2024 · filed on 23 Jul 2025
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
CYTéVIE (SRL) has been based in Comblain-au-Pont since 2001, active in: research and experimental development on other natural sciences and engineering. For 2024, it reports a net loss of 65,381 € and equity of 2,035 €; its revenue is not published. Its solvency stands at 2.5%, below the median of its sector (58.2%).
Companies similar to CYTéVIE
Companies in the same business, of comparable size and area, outside its group.
- Alanine Research and experimental development on natural sciences and engineering Lasne · balance sheet 28,321 €
- IQVIA Cancer Research Research and experimental development on natural sciences and engineering Zaventem · balance sheet €1.07m
- Bimsconsult Research and experimental development on natural sciences and engineering Auderghem · balance sheet 463,296 €
- Mulltron Research and experimental development on natural sciences and engineering Antwerp · balance sheet 80,357 €
- Recherche ET Sante Research and experimental development on natural sciences and engineering Waterloo · balance sheet 75,174 €
- Oxylent Research and experimental development on natural sciences and engineering Ath · balance sheet 97,758 €
- Matteriall Research and experimental development on natural sciences and engineering Leuven · balance sheet 104,898 €
- Pagotini Research and experimental development on natural sciences and engineering Namur · balance sheet 63,313 €
Frequently asked questions about CYTéVIE
What is the revenue of CYTéVIE?
CYTéVIE files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of CYTéVIE?
In Belgium, the VAT number is the company number prefixed with BE: BE0474812921 for CYTéVIE, if the company is VAT-registered. Its company number (CBE) is 0474.812.921.
Where is the registered office of CYTéVIE?
According to the CBE register, the registered office of CYTéVIE is in 4170 Comblain-au-Pont.
What is the equity of CYTéVIE?
At the close of the 2024 financial year, the equity of CYTéVIE amounts to 2,035 €, a solvency of 2.5% of total assets.
Who manages CYTéVIE?
The register lists 4 active mandates at CYTéVIE. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CYTéVIE
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →